Publications
- Immunoglobulin replacement therapy in the Czech Republic: end-of-year 2020 data from the National registry of primary immunodeficiencies2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Czech Hizentra Noninterventional Study With Rapid Push: Efficacy, Safety, Tolerability, and Convenience of Therapy With 20% Subcutaneous Immunoglobulin2019 | Second Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Immunomodulatory effect of immunoglobulins and their use in a treatment of autoimmune diseases2019 | Second Faculty of Medicine
- Possibilities of subcutaneous immunoglobulin therapy - present and future2017 | Second Faculty of Medicine
- New possibilities and perspectives of immunoglobulin therapy2016 | Second Faculty of Medicine
- 20% subcutaneous immunoglobulin therapy2015 | Second Faculty of Medicine
- Clinical outcomes, immunogenicity, and safety of BNT162b22 Vaccine in Primary Antibody Deficiency2023 | Second Faculty of Medicine
- Clinical Outcome of Coronavirus Disease 2019 in Patients with Primary Antibody Deficiencies2023 | Second Faculty of Medicine
- Encapsulation: A Strategy to Deliver Therapeutics and Bioactive Compounds?2023 | Second Faculty of Medicine
- Gastrointestinal Involvement in Primary Antibody Deficiencies2023 | Second Faculty of Medicine
Loading network view...